Microproteomics with microfluidic‐based cell sorting: Application to 1000 and 100 immune cells

Ultimately, cell biology seeks to define molecular mechanisms underlying cellular functions. However, heterogeneity within cell populations must be considered for optimal assay design and data interpretation. Although single‐cell analyses are desirable for addressing this issue, practical considerations, including assay sensitivity, limit their broad application. Therefore, omics studies on small numbers of cells in defined subpopulations represent a viable alternative for elucidating cell functions at the molecular level. MS‐based proteomics allows in‐depth proteome exploration, although analyses of small numbers of cells have not been pursued due to loss during the multistep procedure involved. Thus, optimization of the proteomics workflow to facilitate the analysis of rare cells would be useful. Here, we report a microproteomics workflow for limited numbers of immune cells using non‐damaging, microfluidic chip‐based cell sorting and MS‐based proteomics. Samples of 1000 or 100 THP‐1 cells were sorted, and after enzymatic digestion, peptide mixtures were subjected to nano‐LC‐MS analysis. We achieved reasonable proteome coverage from as few as 100‐sorted cells, and the data obtained from 1000‐sorted cells were as comprehensive as those obtained using 1 μg of whole cell lysate. With further refinement, our approach could be useful for studying cell subpopulations or limited samples, such as clinical specimens.

[1]  W. Elsasser,et al.  Outline of a theory of cellular heterogeneity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[2]  Jeroen Krijgsveld,et al.  Ultrasensitive proteome analysis using paramagnetic bead technology , 2014, Molecular systems biology.

[3]  Jonathan W. Uhr,et al.  Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.

[4]  Rona S. Gertner,et al.  Single-Cell Genomics Unveils Critical Regulators of Th17 Cell Pathogenicity , 2015, Cell.

[5]  J. Foekens,et al.  NanoLC‐FT‐ICR MS improves proteome coverage attainable for ∼3000 laser‐microdissected breast carcinoma cells , 2007, Proteomics.

[6]  C. Weber,et al.  Role and analysis of monocyte subsets in cardiovascular disease , 2016, Thrombosis and Haemostasis.

[7]  Ruben Godoy-Silva,et al.  Computer simulations of the energy dissipation rate in a fluorescence‐activated cell sorter: Implications to cells , 2008, Biotechnology and bioengineering.

[8]  Voichita D. Marinescu,et al.  Simultaneous Multiplexed Measurement of RNA and Proteins in Single Cells , 2015, Cell reports.

[9]  Christopher S. Hughes,et al.  Identification of Maturation-Specific Proteins by Single-Cell Proteomics of Human Oocytes , 2016, Molecular & Cellular Proteomics.

[10]  M. Huss,et al.  HiRIEF LC-MS enables deep proteome coverage and unbiased proteogenomics , 2013, Nature Methods.

[11]  Masaru Tomita,et al.  Microscale phosphoproteome analysis of 10,000 cells from human cancer cell lines. , 2011, Analytical chemistry.

[12]  Lani F. Wu,et al.  Cellular Heterogeneity: Do Differences Make a Difference? , 2010, Cell.

[13]  Ronald J Moore,et al.  Development and evaluation of a micro- and nanoscale proteomic sample preparation method. , 2005, Journal of proteome research.

[14]  Steven P Gygi,et al.  Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry , 2007, Nature Methods.

[15]  H. Clevers,et al.  Highly sensitive proteome analysis of FACS-sorted adult colon stem cells. , 2011, Journal of proteome research.

[16]  J. Foekens,et al.  NanoLC-FT-ICR MS improves proteome coverage attainable for approximately 3000 laser-microdissected breast carcinoma cells. , 2007, Proteomics.

[17]  A. Lamond,et al.  Micro‐proteomics with iterative data analysis: Proteome analysis in C. elegans at the single worm level , 2016, Proteomics.

[18]  K. Shedden,et al.  Quantitative proteomic profiling studies of pancreatic cancer stem cells. , 2010, Journal of proteome research.

[19]  G. Nolan,et al.  Mass Cytometry: Single Cells, Many Features , 2016, Cell.

[20]  Andreas Stengel,et al.  The importance of using the optimal plasticware and glassware in studies involving peptides. , 2011, Analytical biochemistry.

[21]  Kie Kasuga,et al.  Comprehensive analysis of MHC ligands in clinical material by immunoaffinity-mass spectrometry. , 2013, Methods in molecular biology.

[22]  Kazuo Takeda,et al.  Enumeration, characterization, and collection of intact circulating tumor cells by cross contamination‐free flow cytometry , 2011, Cytometry. Part A : the journal of the International Society for Analytical Cytology.

[23]  Shashi K Murthy,et al.  An Integrated Platform for Isolation, Processing, and Mass Spectrometry-based Proteomic Profiling of Rare Cells in Whole Blood* , 2015, Molecular & Cellular Proteomics.

[24]  N. Dovichi,et al.  Quantitative proteomics of Xenopus laevis embryos: expression kinetics of nearly 4000 proteins during early development , 2014, Scientific Reports.

[25]  S. Gordon,et al.  Monocyte and macrophage heterogeneity , 2005, Nature Reviews Immunology.

[26]  R. Sandberg,et al.  Full-Length mRNA-Seq from single cell levels of RNA and individual circulating tumor cells , 2012, Nature Biotechnology.

[27]  A. Gaggar,et al.  Factors Influencing the Measurement of Plasma/Serum Surfactant Protein D Levels by ELISA , 2014, PloS one.

[28]  Peng Wang,et al.  Development of mass spectrometry-based shotgun method for proteome analysis of 500 to 5000 cancer cells. , 2010, Analytical chemistry.

[29]  R. Doolittle,et al.  A simple method for displaying the hydropathic character of a protein. , 1982, Journal of molecular biology.

[30]  B. Simons,et al.  Tracing cellular dynamics in tissue development, maintenance and disease. , 2016, Current opinion in cell biology.